Research And Markets Research And Markets
0 CHECKOUT

India Pharmaceuticals and Healthcare Report Q2 2016

  • ID: 3616028
  • February 2016
  • Region: India
  • 112 pages
  • Business Monitor International
1 of 3

The shift in the pharmaceutical landscape due to the Trans-Pacific Partnership (TPP) will be negative for the Indian generic drug industry. Collectively accounting for 40% of medicine exports fromIndia, the 12 member markets of the TPP will see stronger patent protection and longer regulatory data protection. This coupled with the introduction of a patent linkage system will serve to deter the introduction of Indian generic drugs and curtail their overall growth.

Headline Expenditure Projections

Pharmaceuticals: INR1,066bn (USD16bn) in 2015 to INR1,191bn (17bn) by 2016; +11.7% in local currency terms and 6.4% in US dollar terms. Healthcare: INR5,716bn (USD88bn) in 2015 to INR6,395bn (USD94bn) by 2016; +11.9% in local currency terms and 6.6% in US dollar terms.

Note: Product cover images may vary from those shown
2 of 3

Industry View
Table: Headline PharmaceuticalsHealthcare Forecasts (India 2014-2020)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (India 2012-2020)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (India 2012-2020)

Patented Drug Market Forecast
Table: Selected Patent Developments Affecting Drugmakers
Table: Patented Drug Market Indicators, Historical Data And Forecasts (India 2012-2020)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (India 2012-2020)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (India 2012-2020)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (India 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (India 2014-2020)

Industry Risk Reward Index

Asia Pacific Risk/Reward Index

India Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues
Table: History Of The Indian Patent System
Table:Series Of Setbacks For Innovative Pharmaceutical Firms

Pricing Regime

Market Overview

Healthcare Sector
Table: Healthcare Resources (India 2010-2015)
Table: Healthcare Personnel (India 2010-2015)
Table: Healthcare Activity (India 2010-2015)

Clinical Trials

Epidemiology
Table: Estimated Number Of New Cases Of Cancer In India

Competitive Landscape

Research-Based Industry
Table: Ordinary Members Of OPPI
Table: Multinational Market Activity

Generic Drug Industry

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

Aurobindo Pharmaceutical

Cipla

Dr Reddy's Laboratories

GlaxoSmithKline

MerckCo

Novartis

Pfizer

Sanofi India

Sun Pharmaceutical

Demographic Forecast
Table: Population Headline Indicators (India 1990-2025)
Table: Key Population Ratios (India 1990-2025)
Table: Urban/Rural PopulationLife Expectancy (India 1990-2025)
Table: Population By Age Group (India 1990-2025)
Table: Population By Age Group(India 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db